Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Hydroxocobalamin administration for treatment of vasoplegic syndrome associated with cardiopulmonary bypass causes red plasma.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: American Association Of Blood Banks Country of Publication: United States NLM ID: 0417360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-2995 (Electronic) Linking ISSN: 00411132 NLM ISO Abbreviation: Transfusion Subsets: MEDLINE
- Publication Information:
Original Publication: Arlington, Va. : American Association Of Blood Banks
- Subject Terms:
- References:
Cyanokit package insert. Columbia, MD: Meridian medical technologies; 2017 [cited 2019 Mar 7]. Available from https://www.cyanokit.com/sites/default/files/CYANOKIT_PI_2017.pdf.
Heitzman J, Shen Q, Cazares J, et al. Hydroxocobalamin-colored plasma. Transfusion 2009;49:2555-6.
Gehrie E, Booth G. An unusual case of red plasma. Transfusion 2014;54:11.
Geller RJ, Barthold C, Saiers JA, et al. Pediatric cyanide poisoning: causes, manifestations, management, and unmet needs. Pediatrics 2006;118:2146-58.
Roderique JD, VanDyck K, Holman B, et al. The use of high-dose hydroxocobalamin for vasoplegic syndrome. Ann Thorac Surg 2014;97:1785-6.
Burnes ML, Boettcher BT, Woehlck HJ, et al. Hydroxocobalamin as a rescue treatment for refractory vasoplegic syndrome after prolonged cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2017;31:1012-4.
- Accession Number:
Q40X8H422O (Hydroxocobalamin)
- Publication Date:
Date Created: 20191213 Date Completed: 20200907 Latest Revision: 20200907
- Publication Date:
20221213
- Accession Number:
10.1111/trf.15615
- Accession Number:
31829436
No Comments.